Biophoenix Reports Catalogue

Viewed products

  • The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key M
    The Future...

    The Future of Ophthalmolo- gy Therapeutic- s, ...>>

  • Cancer drugs with apoptotic targets in development July 2010
    Cancer...

    Introductory 15% discount on this new ...>>

Apoptosis: Opportunities in Cancer and Other Diseases

Apoptosis: Opportunities in Cancer and Other Diseases (February 2009)

This report focuses on apoptosis-modulating drugs in cancer, CNS disorders and chronic inflammation/autoimmunity

More details


$1,890.00 tax incl.


 

Apoptosis: Opportunities in Cancer and Other Diseases

 

Authors Sreten Bogdanovic and Beata Langlands

Pages 310

37 Tables and 3 Figures

 

 

Brochure with Table of Contents and Executive Summary

 

Sample pages 

 

 


Contents
Chapter 1 Apoptosis and its regulation
Chapter 2 Assays and biomarkers of apoptosis
Chapter 3 Indirect apoptogens in development for cancer
Chapter 4 Direct apoptogens in development for cancer
Chapter 5 Other apoptosis modulators in development
Chapter 6 Commercial Outlook: Patent and Market Analysis
Chapter 7 Trends and opportunities

 

The following other reports offer comprehensive assessments of the therapy areas most relevant to this report:

Cancer:
Melanoma - Drug Pipeline Analysis and Market Forecasts to 2015
Non-Small-Cell Lung Cancer (NSCLC) - Drug Pipeline Analysis and Market Forecasts to 2015
Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015
Prostate Cancer - Drug Pipeline Analysis and Market Forecasts to 2015
Renal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Cervical Cancer - Pipeline Analysis and Market Forecasts to 2016
Multiple Myeloma - Drug Pipeline Analysis and Market Forecasts to 2016
Ovarian Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Breast Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Colorectal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Bladder Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Acute Myeloid Leukemia - Drug Pipeline Analysis and Market Forecasts to 2016
Brain Tumor - Drug Pipeline Analysis and Market Forecasts to 2016
Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016
Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Stomach Cancer - Drug Pipeline Analysis and Market Forecasts to 2016
Pancreatic Cancer - Drug Pipeline Analysis and Market Forecasts to 2016


CNS Disorders:
Alzheimer’s Disease - Drug Pipeline Analysis and Market Forecasts to 2015
Parkinson's Disease - Drug Pipeline Analysis and Market Forecasts to 2015
Acute Ischemic Stroke - Drug Pipeline Analysis and Market Forecasts to 2015
Muscular Dystrophy - Drug Pipeline Analysis and Market Forecasts to 2016
Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016
Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016


Chronic inflammation/autoimmunity:
Rheumatoid Arthritis - Drug Pipeline Analysis and Market Forecasts to 2015
Psoriasis - Drug Pipeline Analysis and Market Forecasts to 2015
Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015
Atopic Dermatitis - Drug Pipeline Analysis and Market Forecasts to 2016
Osteoarthritis - Drug Pipeline Analysis and Market Forecasts to 2016
Macular Degeneration - Drug Pipeline Analysis and Market Forecasts to 2016

Cart  

(empty)

New products

No new products at this time

Top sellers

Specials